# Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers

> **NCT03835013** · NA · COMPLETED · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 26 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Saline 0.9%
- **DRUG:** Glucagon (25ng/kg/min)
- **DRUG:** Glucagon (50ng/kg/min)
- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT03835013
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-11
- **Primary completion:** 2021-11-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03835013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03835013, "Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03835013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*